VOGLISUG-GM
MRP: 1,485
Packaging: 10x15
Pack Type: tablet
Composition:
Voglibose 0.2mg + Glimepiride 2mg + Metformin HCL 500mg
Indication:
Lowers post-prandial blood glucose levels in type II diabetics, Prevents sudden surge of glucose after meals, Reduces progression of IGT* to Diabetes.
Description:
Voglibose 0.2mg + Glimepiride 2mg + Metformin Hydrochloride 500mg is a triple drug combination used in the management of type 2 diabetes mellitus. This fixed-dose combination targets multiple mechanisms involved in elevated blood glucose, offering comprehensive glycemic control.
Voglibose (0.2mg): An alpha-glucosidase inhibitor that delays carbohydrate digestion and absorption, reducing post-meal glucose spikes.
Glimepiride (2mg): A sulfonylurea that increases insulin secretion from pancreatic beta cells.
Metformin HCl (500mg): A biguanide that reduces hepatic glucose production, improves insulin sensitivity, and slows intestinal absorption of glucose.
This combination is especially beneficial for patients with inadequate glycemic control on monotherapy or dual therapy.
Tags:
- Multi-targeted glycemic control
- Reduces fasting and postprandial blood sugar
- Improves insulin sensitivity and secretion
- Helps in better HbA1c reduction
- Reduces the need for insulin in some patients
- Suitable for patients with high sugar variability
Usage Information
Dosage
Typical Dose: One tablet once daily with food Route: Oral Timing: Usually with breakfast to reduce risk of hypoglycemia Do not skip meals while on this medication Dosage should be based on blood glucose levels and doctor's assessment
Side Effects
Hypoglycemia (low blood sugar) Nausea or stomach upset Flatulence, bloating Diarrhea Headache Skin rash or allergic reaction (rare) Lactic acidosis (very rare but serious with Metformin)
Contraindications
Hypersensitivity to any of the three components Type 1 diabetes Diabetic ketoacidosis Severe renal or hepatic impairment History of lactic acidosis Gastrointestinal disorders (for Voglibose) Pregnancy and lactation (use only if prescribed)
Availability
Voglibose Glimepiride Metformin combination Anti-diabetic triple therapy tablet Metformin 500 + Glimepiride 2 + Voglibose 0.2 Blood sugar control after meals Type 2 diabetes triple drug combo Voglibose 0.2 diabetes medicine Sulfonylurea and biguanide combination Diabetes tablet Glimepiride Metformin Voglibose Triple action sugar control medication Type 2 diabetes oral treatment